Immuneering Corporation announced that its drug atebimetinib, a MEK inhibitor, demonstrated strong potential in combination therapies for pancreatic ductal adenocarcinoma and anaplastic thyroid cancer. The drug showed a median overall survival of 17.3 months in Phase 2 pancreatic cancer trials and is currently in a Phase 3 trial. New preclinical data supports its use across multiple cancer types, with presentations scheduled at the 2026 EORTC-NCI-AACR Symposium. These findings reinforce atebimetinib's potential to improve survival and treatment options in aggressive cancers.
Immuneering's atebimetinib drug is highlighted alongside a strong health sector performance on Pluang. For readers following health stocks, here is Pluang's market snapshot as of Nov 04, 2026 18:41 WIB: out of 150 priced US health-sector stocks, 118 rose and 24 fell. Notable movers include CGC at USD 0.75 (+6.13%) with 100% buy orders, TLRY at USD 2.81 (+6.04%) with 96% sell orders, and INO at USD 1.76 (+6.02%) with 53% sell orders.
KE Holdings Inc., a major online and offline housing platform in China, will announce its unaudited financial results for the third quarter of 2026 on November 16 before the U.S. market opens. The company will host an earnings conference call at 7:00...
JD.com announced it will publish its unaudited financial results for the third quarter of 2026 on November 17, before the U.S. market opens. The company's management will hold a conference call the same day to discuss the results, providing investors...
Dimensional Fund Advisors Ltd. filed a Form 8.3 disclosure revealing it holds a 1.27% stake in Prologis Inc as of November 3, 2026. This disclosure is part of regulatory requirements under the Takeover Code for investors holding 1% or more in relevan...
Dimensional Fund Advisors Ltd. has disclosed an interest in 1,516,595 ordinary shares of DCC Energy plc, representing 1.78% of the company's shares as of November 3, 2026. The disclosure follows regulatory requirements under the Irish Takeover Panel ...
Scage Future's subsidiary Guizhou Scage Tech Ltd. signed a strategic cooperation agreement with China Huaye Group to collaborate on infrastructure, mining, renewable energy, and technology projects. They plan to deploy up to 1,000 autonomous electric...
